HIV linked to greater increase in cardiovascular disease risk for women than men
Top 5 stories on long-term health for people living with HIV from CROI 2026
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable
Statin treatment reduces blood pressure in people with HIV, REPRIEVE trial shows
Integrase inhibitors reduce heart risks in people with HIV in the US
Too few people with HIV receiving statins despite guideline changes
Women with HIV have no cardiovascular advantage over men, unlike in the general population
Few people with HIV in England starting statins despite new recommendations
Beyond cholesterol: statins may protect heart health in people with HIV through multiple mechanisms
